Angelo Gordon & Co., L.P. Catalent, Inc. Transaction History
Angelo Gordon & Co., L.P.
- $209 Million
- Q3 2025
Shares
2 transactions
Others Institutions Holding CTLT
# of Institutions
44Shares Held
16.5MCall Options Held
10.7KPut Options Held
4.5K-
Black Rock Inc. New York, NY15.4MShares$975 Million0.02% of portfolio
-
Segantii Capital Management LTD250KShares$15.9 Million1.75% of portfolio
-
Credit Suisse Ag Zurich, V8210KShares$13.3 Million0.01% of portfolio
-
Eaton Vance Management Boston, MA189KShares$12 Million0.02% of portfolio
-
Eisler Capital (Uk) Ltd. London, X0165KShares$10.5 Million0.05% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $11.4B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...